Heart Assistance Device, BYPA Medical Solutions, Apr 9
Summary
USPTO published patent application US20260097196A1 for a heart assistance device developed by BYPA Medical Solutions. The device uses a linear actuator to move a membrane in a chamber, creating pulsating fluid flow synchronized with patient ECG signals. The control unit calculates timing offsets between QRS complex detection and ejection phase initiation.
What changed
USPTO published patent application US20260097196A1 for a heart assistance device comprising a linear actuator configured to move a membrane in a chamber to create pulsating fluid flow supporting cardiac function. The device includes a control unit that processes patient ECG signals, specifically detecting the QRS complex and determining the timing offset between QRS detection and ejection phase initiation to synchronize assistance with native heart activity.
Medical device manufacturers developing cardiac support systems should monitor this application as potential prior art. The patent describes ECG-synchronized pulsatile flow technology that may overlap with existing or planned circulatory support device designs. BYPA Medical Solutions, with inventor Bertrand de Brosses, seeks protection for the complete heart assistance or backup system including the linear actuator mechanism and adaptive control algorithms.
What to do next
- Monitor for updates on patent examination status
- Review claims for potential infringement implications
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
HEART ASSISTANCE OR BACK-UP DEVICE
Application US20260097196A1 Kind: A1 Apr 09, 2026
Assignee
BYPA MEDICAL SOLUTIONS
Inventors
Bertrand DE BROSSES
Abstract
A device for the temporary circulatory assistance or back-up of the heart of a patient including: a linear actuator configured to move a membrane in a chamber so as to cause a pulsating fluid flow adapted to support the activity of the heart of the patient, which flow is characterised by a succession of phases of aspiration and phases of ejection of the fluid, a control unit configured to pilot the actuator and control the movement of the membrane, which piloting is carried out while taking into account input data originating from an ECG signal of the patient, the control unit is configured to determine a time offset between the instant at which the QRS complex of the ECG signal is detected and the instant at which an ejection phase is initiated.
CPC Classifications
A61M 60/546 A61M 60/113 A61M 60/117 A61M 60/268 A61M 60/38 A61M 60/441 A61M 2230/06
Filing Date
2023-08-28
Application No.
19111817
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.